Dr Patrick Vermersch gives us his thoughts on tailoring multiple sclerosis treatment to the individual patient. Part 3 of 3.
View part 1 here.
View part 2 here.
Speaker disclosures: Honoraria, consulting fees and research support from Roche, Biogen, Sanofi, Novartis, Servier, Merck, Alimera Sciences and Teva.
Filmed at the American Academy of Neurology (AAN) Annual Meeting, Boston, US, April 2017